MDM2 and inflammatory myofibroblastic tumor: This case demonstrates that there may also be a role for MDM2 studies to exclude a diagnosis of WDLPS with extreme sclerosis in patients apparently presenting with a retroperitoneal inflammatory pseudotumor.